PRO141 ESTIMATING UTILITY WEIGHTS IN HEMOPHILIA A PATIENTS WITH INHIBITORS USING THE EQ-5D-5L TOOL: A COMPARISON OF EMICIZUMAB PROPHYLAXIS VERSUS ON-DEMAND TREATMENT WITH BYPASSING AGENTS
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.2470
https://www.valueinhealthjournal.com/article/S1098-3015(19)34848-X/fulltext
Section Title :
Section Order :
12161
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34848-X&doi=10.1016/j.jval.2019.09.2470